Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 3,298 | 7,286 | 4,064 | 2,107 | 3,310 |
| Operating Income | -3,298 | -7,286 | -4,064 | -2,107 | -3,310 |
| Other Income | 12 | 24 | -9 | 29 | 0 |
| Pre-tax Income | -3,286 | -7,263 | -4,073 | -2,078 | -3,310 |
| Net Income Continuous | -3,286 | -7,263 | -4,073 | -2,078 | -3,310 |
| Net Income | $-3,286 | $-7,263 | $-4,073 | $-2,078 | $-3,310 |
| EPS Basic Total Ops | -0.36 | -0.80 | -0.62 | 8.70 | -0.64 |
| EPS Basic Continuous Ops | -0.36 | -0.80 | -0.62 | 7.72 | -0.64 |
| EPS Diluted Total Ops | -0.36 | -0.80 | -0.62 | 8.70 | -0.64 |
| EPS Diluted Continuous Ops | -0.36 | -0.80 | -0.62 | 7.72 | -0.64 |
| EBITDA(a) | $-3,286 | $-7,273 | $-4,050 | $-2,092 | $-3,299 |